Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FHD43
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,805
Award facts
- Contract value 100% obligated
- $2,804.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,804.94 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, with an ultimate completion date of May 28, 2025. This delivery order utilizes a firm fixed price contract structure and does not include a set-aside designation, indicating it was awarded through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. This award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its prime IDC with DLA to fulfill critical medical supply needs across the federal healthcare system, including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver a wide range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular vaccine delivery order exemplifies AmerisourceBergen's role as a critical vendor supporting military and veteran healthcare systems through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FHD43?
SPE2DB25FHD43 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 27, 2025.
How much is contract SPE2DB25FHD43 worth?
The government has obligated $2,805 on SPE2DB25FHD43.
Is contract SPE2DB25FHD43 an order under another contract?
Yes. SPE2DB25FHD43 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHD43 competed?
The extent of competition for SPE2DB25FHD43 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award